TLN-254

· Treeline Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLN-254, covering 2025-10-10 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma [Phase 1]